Chinnappan J, Ramu A, V V, S A
Sci Rep. 2021; 11(1):22036.
PMID: 34764329
PMC: 8586365.
DOI: 10.1038/s41598-021-01508-8.
Cai S, Deng Y, Peng H, Shen J
Front Oncol. 2021; 11:723341.
PMID: 34540692
PMC: 8446639.
DOI: 10.3389/fonc.2021.723341.
Alimoradi N, Firouzabadi N, Fatehi R
Cancer Cell Int. 2021; 21(1):207.
PMID: 33849540
PMC: 8045276.
DOI: 10.1186/s12935-021-01921-z.
Wang Y, Wang W, Su C, Hsu C, Yuan S, Chen Y
J Dent Sci. 2021; 16(1):21-28.
PMID: 33384774
PMC: 7770302.
DOI: 10.1016/j.jds.2020.07.013.
Zhao M, Wang Y, Liu Y, Zhang W, Liu Y, Yang X
Cancer Biol Ther. 2019; 20(12):1430-1442.
PMID: 31441380
PMC: 6804814.
DOI: 10.1080/15384047.2019.1647051.
HGF/c-MET Signaling in Melanocytes and Melanoma.
Czyz M
Int J Mol Sci. 2018; 19(12).
PMID: 30513872
PMC: 6321285.
DOI: 10.3390/ijms19123844.
miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2.
Zhao Q, Chen S, Zhu Z, Yu L, Ren Y, Jiang M
Cell Death Dis. 2018; 9(12):1157.
PMID: 30464258
PMC: 6249286.
DOI: 10.1038/s41419-018-1182-9.
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
Saini M, Verma A, Mathew S
Cell Death Dis. 2018; 9(2):237.
PMID: 29445192
PMC: 5833614.
DOI: 10.1038/s41419-018-0261-2.
Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X, Hicks K, Neumann P, Patel T
PLoS One. 2017; 12(2):e0171616.
PMID: 28196140
PMC: 5308774.
DOI: 10.1371/journal.pone.0171616.
Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts.
Conte F, Oti M, Dixon J, Carels C, Rubini M, Zhou H
Hum Genet. 2015; 135(1):41-59.
PMID: 26561393
PMC: 4698300.
DOI: 10.1007/s00439-015-1606-x.
MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K, Zhang K, Osman I, Honda K, Jobava R, Bedogni B
Oncotarget. 2015; 6(32):33512-22.
PMID: 26392417
PMC: 4741782.
DOI: 10.18632/oncotarget.5258.
Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract.
Lovicu F, Shin E, McAvoy J
Exp Eye Res. 2015; 142:92-101.
PMID: 26003864
PMC: 4654713.
DOI: 10.1016/j.exer.2015.02.004.
Sprouty2 mediated tuning of signalling is essential for somite myogenesis.
Abu-Elmagd M, Goljanek Whysall K, Wheeler G, Munsterberg A
BMC Med Genomics. 2015; 8 Suppl 1:S8.
PMID: 25783674
PMC: 4315326.
DOI: 10.1186/1755-8794-8-S1-S8.
Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.
Ramasamy S, Bennet D, Kim S
Int J Nanomedicine. 2014; 9:5789-809.
PMID: 25525360
PMC: 4266242.
DOI: 10.2147/IJN.S71128.
The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells.
Masoumi-Moghaddam S, Amini A, Ehteda A, Wei A, Morris D
J Ovarian Res. 2014; 7:61.
PMID: 24932220
PMC: 4058002.
DOI: 10.1186/1757-2215-7-61.
The developing story of Sprouty and cancer.
Masoumi-Moghaddam S, Amini A, Morris D
Cancer Metastasis Rev. 2014; 33(2-3):695-720.
PMID: 24744103
PMC: 4113681.
DOI: 10.1007/s10555-014-9497-1.
c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S
J Biol Chem. 2013; 288(25):18121-33.
PMID: 23649631
PMC: 3689956.
DOI: 10.1074/jbc.M113.478560.
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Patel R, Gao M, Ahmad I, Fleming J, Singh L, Rai T
J Clin Invest. 2013; 123(3):1157-75.
PMID: 23434594
PMC: 3582117.
DOI: 10.1172/JCI63672.
Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines.
Moghaddam S, Amini A, Wei A, Pourgholami M, Morris D
J Oncol. 2012; 2012:373826.
PMID: 23251157
PMC: 3517860.
DOI: 10.1155/2012/373826.
Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract.
Shin E, Basson M, Robinson M, McAvoy J, Lovicu F
Mol Med. 2012; 18:861-73.
PMID: 22517312
PMC: 3409273.
DOI: 10.2119/molmed.2012.00111.